TULBAH, A. S. Formulation and in vitro characterization of inhalable dasatinib-nanoemulsion as a treatment potential against A549 and Calu-3 lung cancer cells. International Journal of Health Sciences, [S. l.], v. 19, n. 1, p. 4–14, 2025. Disponível em: https://pub.qu.edu.sa/index.php/journal/article/view/8643. Acesso em: 12 jan. 2025.